ICER Finds GLP-1s Are Cost-Effective, But Pose Big Budget Concerns

By Luke Zarzecki / September 17, 2025 at 3:35 PM

The Institute for Clinical and Economic Review (ICER) released a draft evidence report on GLP-1 drugs that found the medications are cost-effective and clinically effective, but also warned they pose affordability concerns, coming as lawmakers and regulators try to determine how to move forward with the drugs.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.